Measures of oxidative stress

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Biomarker Discovery

Background:

• Oxidative stress plays a key role in atherosclerosis.
• Current cardiovascular risk prediction models can be improved with more specific biomarkers.
• In vivo markers of oxidative stress are needed for accurate disease assessment.

Purpose of the Study:

• To review the pathophysiology of oxidized low-density lipoprotein (OxLDL) and isoprostanes as potential cardiovascular biomarkers.
• To describe the rationale and methodologies for measuring OxLDL and isoprostanes.
• To elucidate the role of these biomarkers in reflecting pathophysiology and predicting cardiovascular risk.

Main Methods:

• Review of pathophysiology of OxLDL and isoprostanes.
• Description of current assay methodologies for OxLDL and isoprostanes, including their pros and cons.
• Analysis of clinical investigations (epidemiological, case-control, prospective studies).

Main Results:

• OxLDL and isoprostanes show promise as plasma biomarkers for cardiovascular risk prediction.
• Existing methodologies for measuring these biomarkers have varying advantages and disadvantages.
• Clinical studies suggest these biomarkers reflect underlying pathophysiology and aid in risk stratification.

Conclusions:

• In vivo oxidative stress markers like OxLDL and isoprostanes are valuable for cardiovascular risk assessment.
• Further development and validation of assays are needed for clinical application.
• These biomarkers hold significant potential for improving cardiovascular medicine and predicting clinical events.